(New Playbook) Human evidence is everything in biotech. It’s the proof that a new therapeutic works, the foundation for investor belief, and the floodgate for real-world patient impact. This is why us @CompoundVC have written a playbook on how biotech companies can get human evidence as fast as possible. - Expanded Access, Phase 0, n-of-1 studies, Geographic and Regulatory Arbitrage, Human Challenge Trials, and Braindead Cadavers are underused paths - 40M die each year from non-infectious disease; patients which should have the option to take new therapies, sooner Exploiting these paths could lead to a safe and expeditious path towards a new Golden Age of drug discovery.